Lai Wang's most recent trade in BeiGene Ltd - ADR was a trade of 1,068 American Depositary Shares done at an average price of $276.7 . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Sale of securities on an exchange or to another person at price $ 276.74 per share. | 23 Jun 2026 | 1,068 | 0 (0%) | 0% | 276.7 | 295,553 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Sale of securities on an exchange or to another person at price $ 265.39 per share. | 16 Jun 2026 | 1,169 | 0 (0%) | 0% | 265.4 | 310,236 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | 11 Jun 2026 | 229,775 | 229,775 | - | - | Share Option (Right to Buy) | ||
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 118,625 | 1,710,085 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Sale of securities on an exchange or to another person at price $ 261.00 per share. | 11 Jun 2026 | 756 | 0 (0%) | 0% | 261.0 | 197,318 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Sale of securities on an exchange or to another person at price $ 269.34 per share. | 08 Jun 2026 | 1,327 | 40 (0%) | 0% | 269.3 | 357,418 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Sale of securities on an exchange or to another person at price $ 270.72 per share. | 08 Jun 2026 | 40 | 0 (0%) | 0% | 270.7 | 10,829 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 112,606 | 1,564,030 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 55,029 | 1,619,059 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | President, Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 427,895 | 1,451,424 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 350.06 per share. | 09 Sep 2025 | 5,000 | 0 (0%) | 0% | 350.1 | 1,750,312 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 302.00 per share. | 29 Jul 2025 | 2,949 | 1,351 (0%) | 0% | 302.0 | 890,596 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 304.16 per share. | 29 Jul 2025 | 800 | 259 (0%) | 0% | 304.2 | 243,330 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 302.92 per share. | 29 Jul 2025 | 292 | 1,059 (0%) | 0% | 302.9 | 88,454 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 305.00 per share. | 29 Jul 2025 | 259 | 0 (0%) | 0% | 305 | 78,995 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 300.00 per share. | 18 Jul 2025 | 700 | 0 (0%) | 0% | 300 | 210,000 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 23 Jun 2025 | 1,028 | 0 (0%) | 0% | 260 | 267,280 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 266.40 per share. | 16 Jun 2025 | 1,177 | 470 (0%) | 0% | 266.4 | 313,558 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 251.37 per share. | 16 Jun 2025 | 470 | 0 (0%) | 0% | 251.4 | 118,142 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | 10 Jun 2025 | 162,565 | 162,565 | - | - | Share Option (Right to Buy) | ||
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 86,359 | 1,058,304 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 250.71 per share. | 06 Jun 2025 | 600 | 802 (0%) | 0% | 250.7 | 150,425 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 253.19 per share. | 06 Jun 2025 | 300 | 300 (0%) | 0% | 253.2 | 75,956 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 255.30 per share. | 06 Jun 2025 | 300 | 0 (0%) | 0% | 255.3 | 76,590 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 251.89 per share. | 06 Jun 2025 | 202 | 600 (0%) | 0% | 251.9 | 50,882 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 69,251 | 990,171 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 258.73 per share. | 21 Feb 2025 | 1,782 | 400 (0%) | 0% | 258.7 | 461,058 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 254.82 per share. | 21 Feb 2025 | 1,327 | 3,673 (0%) | 0% | 254.8 | 338,149 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 255.86 per share. | 21 Feb 2025 | 575 | 3,098 (0%) | 0% | 255.9 | 147,117 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 256.70 per share. | 21 Feb 2025 | 479 | 2,619 (0%) | 0% | 256.7 | 122,957 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 258.18 per share. | 21 Feb 2025 | 437 | 2,182 (0%) | 0% | 258.2 | 112,826 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 260.17 per share. | 21 Feb 2025 | 400 | 0 (0%) | 0% | 260.2 | 104,067 | American Depositary Shares |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 220.35 per share. | 27 Sep 2024 | 5,000 | 0 (0%) | 0% | 220.4 | 1,101,774 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 220.35 per share. | 27 Sep 2024 | 5,000 | 0 (0%) | 0% | 220.4 | 1,101,774 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.80 per share. | 24 Jun 2024 | 1,062 | 2 (0%) | 0% | 159.8 | 169,708 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.80 per share. | 24 Jun 2024 | 1,062 | 2 (0%) | 0% | 159.8 | 169,708 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 24 Jun 2024 | 2 | 0 (0%) | 0% | 161 | 322 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 24 Jun 2024 | 2 | 0 (0%) | 0% | 161 | 322 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 153.75 per share. | 17 Jun 2024 | 841 | 0 (0%) | 0% | 153.8 | 129,305 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 153.75 per share. | 17 Jun 2024 | 841 | 0 (0%) | 0% | 153.8 | 129,305 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.42 per share. | 17 Jun 2024 | 485 | 1,141 (0%) | 0% | 159.4 | 77,321 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.42 per share. | 17 Jun 2024 | 485 | 1,141 (0%) | 0% | 159.4 | 77,321 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.00 per share. | 17 Jun 2024 | 478 | 1,626 (0%) | 0% | 159.0 | 76,001 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.00 per share. | 17 Jun 2024 | 478 | 1,626 (0%) | 0% | 159.0 | 76,001 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.90 per share. | 17 Jun 2024 | 300 | 841 (0%) | 0% | 159.9 | 47,971 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.90 per share. | 17 Jun 2024 | 300 | 841 (0%) | 0% | 159.9 | 47,971 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 158.50 per share. | 17 Jun 2024 | 237 | 2,104 (0%) | 0% | 158.5 | 37,565 | American Depositary Shares |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 158.50 per share. | 17 Jun 2024 | 237 | 2,104 (0%) | 0% | 158.5 | 37,565 | - |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 318,253 | 318,253 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 168,935 | 1,768,962 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 168,935 | 1,768,962 (0%) | 0% | 0 | - | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 181.91 per share. | 26 Jun 2023 | 1,103 | 5 (0%) | 0% | 181.9 | 200,652 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 183.20 per share. | 26 Jun 2023 | 5 | 0 (0%) | 0% | 183.2 | 916 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 133,627 | 1,614,431 (0%) | 0% | 0 | - | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 192.42 per share. | 15 Jun 2023 | 1,325 | 0 (0%) | 0% | 192.4 | 254,955 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 224.04 per share. | 07 Jun 2023 | 161 | 227 (0%) | 0% | 224.0 | 36,070 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 226.16 per share. | 07 Jun 2023 | 116 | 0 (0%) | 0% | 226.2 | 26,234 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 225.27 per share. | 07 Jun 2023 | 111 | 116 (0%) | 0% | 225.3 | 25,005 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 223.23 per share. | 07 Jun 2023 | 74 | 388 (0%) | 0% | 223.2 | 16,519 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 177.33 per share. | 27 Jun 2022 | 458 | 0 (0%) | 0% | 177.3 | 81,215 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 125,255 | 1,509,989 (0%) | 0% | 0 | - | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 149.01 per share. | 17 Jun 2022 | 723 | 0 (0%) | 0% | 149.0 | 107,734 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 139.40 per share. | 17 Jun 2022 | 445 | 723 (0%) | 0% | 139.4 | 62,034 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 142.00 per share. | 06 Jun 2022 | 660 | 0 (0%) | 0% | 142.0 | 93,718 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.49 per share. | 17 May 2022 | 999,999 | 1,408,498 (0%) | 0% | 3.5 | 3,489,997 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.29 per share. | 17 May 2022 | 233,948 | 408,499 (0%) | 0% | 2.3 | 535,741 | - |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2021 | 58,188 | 174,551 (0%) | 0% | 0 | - | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2021 | 58,188 | 0 (0%) | 0% | 0 | - | |
| BeiGene Ltd (ADR) | Dr. Lai Wang, PhD | Global Head of R&D | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2021 | 58,188 | 58,188 (0%) | 0% | 0 | - |